Question 1

What is the catalog number for Imatinib (pyridine) -N-oxide?

Accepted Answer

The catalog number for Imatinib (pyridine) -N-oxide is 280395.

Question 2

What sizes are available for Imatinib (pyridine) -N-oxide?

Accepted Answer

Imatinib (pyridine) -N-oxide is available in the following size(s): 1 mg, 2 mg, 5 mg, 10 mg, 25 mg.

Question 3

How many pack sizes does Imatinib (pyridine) -N-oxide come in?

Accepted Answer

Imatinib (pyridine) -N-oxide is available in 5 different pack sizes.

Question 4

Is Imatinib (pyridine) -N-oxide in stock?

Accepted Answer

Imatinib (pyridine) -N-oxide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 7

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Imatinib (pyridine) -N-oxide

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

H-D-Ala-phe-oh

Ethyl 4-Amino-2-fluorobenzoate

Tissue FFPE Sections, Spleen

Carcinoembryonic Antigen (CEA) / CD66 (C66/1983R), CF594 conjugate, 0.1mg/mL

Tectb Mouse Gene Knockout Kit (CRISPR)

INO80D Human Gene Knockout Kit (CRISPR)